{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:10Z","timestamp":1790916790700,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":148,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101271","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:09:15Z","timestamp":1780337355000},"page":"101271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advances in the management of small cell lung cancer: thoracic and cranial radiation therapy and sequencing with systemic therapy"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-011X","authenticated-orcid":false,"given":"Dionee","family":"Liefman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101271_bib0001","doi-asserted-by":"crossref","unstructured":"Rudin, C.M., Brambilla, E., Faivre-Finn, C. et al. Small-cell lung cancer. Nat. Rev. Dis. Primers.. 2021; 7, 3 (2021). https:\/\/doi.org\/10.1038\/s41572-020-00235-0.","DOI":"10.1038\/s41572-020-00235-0"},{"key":"10.1016\/j.ctarc.2026.101271_bib0002","series-title":"Small Cell Lung Cancer. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL)","author":"Basumallik","year":"2025"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening and early detection","volume":"18","author":"Wang","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0004","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database","volume":"24","author":"Govindan","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/JTO.0b013e31815bdc0d","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals regarding the clinical Staging of small cell Lung Cancer in the forthcoming (Seventh) edition of the tumor, node, metastasis classification for Lung Cancer","volume":"2","author":"Shepherd","year":"2007","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101271_bib0006","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/JTO.0b013e3181b27799","article-title":"The IASLC Lung cancer Staging Project","volume":"4","author":"Vallieres","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0007","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0169-5002(89)90156-6","article-title":"Staging and prognostic factors in small cell lung cancer: a consensus report","volume":"5","author":"Stahel","year":"1989","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ctarc.2026.101271_bib0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/JTO.0b013e318194a355","article-title":"The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM edition","volume":"4","author":"Ignatius Ou","year":"2009","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0009","article-title":"NCCN Guidelines\u00ae: Small cell Lung Cancer, version 2.2026","volume":"24","author":"Ganti","year":"2026","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101271_bib0010","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/cancers13030390","article-title":"Surgery in small-cell lung cancer","volume":"13","author":"Martucci","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctarc.2026.101271_bib0011","doi-asserted-by":"crossref","first-page":"320S","DOI":"10.1378\/chest.106.6_Supplement.320S","article-title":"A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy","volume":"106","author":"Lad","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.ctarc.2026.101271_bib0012","series-title":"An interactive website for SEER cancer statistics [Internet]","year":"2024"},{"key":"10.1016\/j.ctarc.2026.101271_bib0013","doi-asserted-by":"crossref","DOI":"10.1378\/chest.12-2363","article-title":"Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Jett","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ctarc.2026.101271_bib0014","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1158\/2159-8290.CD-12-0112","article-title":"Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1","volume":"2","author":"Byers","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ctarc.2026.101271_bib0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101271_bib0016","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101271_bib0017","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.celrep.2016.06.081","article-title":"ASCL1 and NEUROD1 reveal heterogeneity in pulmonary neuroendo- crine tumors and regulate distinct genetic programs","volume":"16","author":"Borromeo","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.12.004","article-title":"Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101271_bib0019","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.3390\/curroncol30070449","article-title":"Management of very early small cell lung cancer: A Canadian survey study","volume":"30","author":"Malakouti-Nejad","year":"2023","journal-title":"Curr. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101271_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline","volume":"10","author":"Simone","year":"2020","journal-title":"Pr. Radiat Oncol"},{"key":"10.1016\/j.ctarc.2026.101271_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lungcan.2016.11.009","article-title":"Trends in stereotactic body radiation therapy for stage I small cell lung cancer","volume":"103","author":"Stahl","year":"2017","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/curroncol30010008","article-title":"Stereotactic body radiotherapy (SBRT) in very limited-stage small cell lung cancer (VLS-SCLC)","volume":"30","author":"Mercier","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/1533033818783904","article-title":"Clinical outcomes of stereotactic body radiotherapy for patients with stage I small-cell lung cancer: analysis of a subset of the Japanese Radiological Society multi-institutional SBRT study group database","volume":"17","author":"Shioyama","year":"2018","journal-title":"Technol. Cancer Res. Treat."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101271_bib0024","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small-cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N.Engl.J.Med"},{"key":"10.1016\/j.ctarc.2026.101271_bib0025","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/annonc\/mdw263","article-title":"Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis","volume":"27","author":"De Ruysscher","year":"2016","journal-title":"Ann. Oncol."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101271_bib0026","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa2404873","article-title":"Durvalumab after chemoradiotherapy in limited-stage small-cell lung cancer","volume":"391","author":"Cheng","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctarc.2026.101271_bib0027","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104","volume":"20","author":"Takada","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0028","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1200\/JCO.2004.01.178","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer","volume":"22","author":"Fried","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0029","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ctrv.2007.03.002","article-title":"Timing of chest radiotherapy in patients with limited stage small cell lung cancer: A systematic review and meta- analysis of randomised controlled trials","volume":"33","author":"Pijls-Johannesma","year":"2007","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ctarc.2026.101271_bib0030","first-page":"17","article-title":"Population-based results of chemoradiotherapy for limited stage small cell lung cancer in the Netherlands","volume":"30","author":"Damhuis","year":"2018","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101271_bib0031","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cllc.2016.07.009","article-title":"Effect of thoracic radio- therapy timing and fractionation on survival in nonmetastatic small cell lung carcinoma","volume":"18","author":"Wong","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101271_bib0032","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","article-title":"Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis","volume":"10","author":"Warde","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101271_bib0033","first-page":"1446","article-title":"Proliferation of small cell lung cancer cells: a mechanism for rapid growth and resistance","volume":"5","author":"Murray","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0034","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrc1650","article-title":"Repopulation of cancer cells during therapy: an important cause of treatment failure","volume":"5","author":"Kim","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101271_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0036","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101271_bib0037","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0038","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijrobp.2013.05.040","article-title":"Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer","volume":"87","author":"Shirvani","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101271_bib0039","doi-asserted-by":"crossref","unstructured":"Faivre-Finn, Corinne et al. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. Lancet Oncol., Volume 18, Issue 8, 1116-1125.","DOI":"10.1016\/S1470-2045(17)30318-2"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101271_bib0040","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ijrobp.2024.02.063","article-title":"Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small cell lung cancer: A brief report from the CONVERT trial","volume":"119","author":"Walls","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101271_bib0041","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1200\/JCO.22.01359","article-title":"High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer: CALGB 30610 (Alliance)\/RTOG 0538","volume":"41","author":"Bogart","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101271_bib0042","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S2213-2600(24)00189-9","article-title":"High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial","volume":"12","author":"Yu","year":"2024","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101271_bib0043","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(20)30742-7","article-title":"High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"22","author":"Gr\u00f8nberg","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0044","doi-asserted-by":"crossref","unstructured":"Gr\u00f8nberg, B.H., Killingberg, K.T., Fl\u00f8tten, \u00d8. et al., in press. High-dose versus standard-dose twice-daily thoracic radiotherapy in limited-stage SCLC: final survival data, long-term toxicity, and relapse patterns in a randomized, open-label, phase II trial. J. Thorac. Oncol., [In press] Available at: https:\/\/doi.org\/10.1016\/j.jtho.2025.04.007.","DOI":"10.1016\/j.jtho.2025.04.007"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101271_bib0045","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO-25-01569","article-title":"Chemoradiation \u00b1 atezolizumab in limited-stage small cell lung cancer: results of NRG Oncology\/Alliance LU005","volume":"44","author":"Higgins","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0046","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13073-019-0653-7","article-title":"Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system","volume":"11","author":"Lhuillier","year":"2019","journal-title":"Genome Med."},{"key":"10.1016\/j.ctarc.2026.101271_bib0047","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13045-024-01587-w","article-title":"Regimens combining radiation and immunotherapy for cancer: latest updates from 2024 ASCO Annual Meeting","volume":"17","author":"Liu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0048","doi-asserted-by":"crossref","first-page":"10131","DOI":"10.2147\/IJGM.S342009","article-title":"Brain metastasis in patients with small cell lung cancer","volume":"14","author":"Li","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.ctarc.2026.101271_bib0049","first-page":"476","volume":"341","author":"Aup\u00e9rin","year":"1999"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101271_bib0050","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2013.02.033","article-title":"Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214","volume":"15","author":"Gondi","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101271_bib0051","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/annonc\/mdq576","volume":"22","author":"Le P\u00e9choux","year":"2011","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101271_bib0052","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","article-title":"Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)","volume":"16","author":"Belderbos","year":"2021","journal-title":"J. Thorac. Oncol."},{"issue":"28","key":"10.1016\/j.ctarc.2026.101271_bib0053","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): A GICOR-GOECP-SEOR study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"32","key":"10.1016\/j.ctarc.2026.101271_bib0054","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1200\/JCO-25-00221","article-title":"NRG oncology. Hippocampal avoidance during prophylactic cranial irradiation for patients with small cell lung cancer: randomized phase II\/III trial NRG-CC003","volume":"43","author":"Gondi","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0055","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier: NCI-2019-05338. SWOG S1827 (MAVERICK) testing whether the use of brain scans alone instead of brain scans plus preventive brain radiation affects lifespan in patients with small cell lung cancer. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04155034 [cited: 5th October 2024]."},{"key":"10.1016\/j.ctarc.2026.101271_bib0056","doi-asserted-by":"crossref","unstructured":"Levy A, Berghmans T, Koller M, et al. PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients. Lung Cancer. 2024 Dec;198:107993. doi: 10.1016\/j.lungcan.2024.107993.","DOI":"10.1016\/j.lungcan.2024.107993"},{"issue":"23","key":"10.1016\/j.ctarc.2026.101271_bib0057","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","article-title":"First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer","volume":"379","author":"Horn","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0058","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial","volume":"22","author":"Goldman","year":"2021","journal-title":"Lancet Oncol."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101271_bib0059","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1200\/JCO.20.00793","article-title":"Pembrolizumab or Placebo Plus Etoposide and Platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study","volume":"38","author":"Rudin","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"9962","key":"10.1016\/j.ctarc.2026.101271_bib0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","article-title":"Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial","volume":"385","author":"Slotman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2026.101271_bib0061","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.lungcan.2017.03.007","article-title":"Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial","volume":"108","author":"Slotman","year":"2017","journal-title":"Lung Cancer"},{"issue":"9975","key":"10.1016\/j.ctarc.2026.101271_bib0062","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0140-6736(15)60679-1","article-title":"Radiotherapy for extensive stage small-cell lung cancer - authors' reply","volume":"385","author":"Slotman","year":"2015","journal-title":"LancetLancet"},{"key":"10.1016\/j.ctarc.2026.101271_bib0063","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jtho.2019.10.001","article-title":"Phase I trial of Pembrolizumab and radiation therapy after induction chemotherapy for extensive-stage small cell lung cancer","volume":"15","author":"Welsh","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0064","unstructured":"Australian New Zealand Clinical Trials Registry [Internet]. Sydney (NSW): NHMRC Clinical Trials Centre, University of Sydney (Australia); 2021; Identifier ACTRN12621000586819. A phase II study of platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first line treatment of patients with extensive-stage small-cell lung cancer. [cited 4th October 2024]. Available from: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=381223."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12885-022-10074-9","article-title":"Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in small cell LUng CanceR extensive disease \u2013 a randomized, open-label, multicenter phase II trial","volume":"22","author":"Bozorgmehr","year":"2022","journal-title":"BMC. Cancer"},{"key":"10.1016\/j.ctarc.2026.101271_bib0066","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1200\/JCO.20.01055","article-title":"Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)","volume":"39","author":"Liu","year":"2021","journal-title":"JCO"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101271_bib0067","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ijrobp.2020.09.020","article-title":"Patterns of disease progression after carboplatin\/etoposide + atezolizumab in extensive-stage small-cell lung cancer (ES-SCLC)","volume":"108","author":"Higgins","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctarc.2026.101271_bib0069","article-title":"TROG 20.01 CHEST RT: chemotherapy and immunotherapy in extensive-stage small-cell lung cancer with thoracic radiotherapy","year":"2021","journal-title":"Aust. N. Z. Clin. Trials Regist."},{"key":"10.1016\/j.ctarc.2026.101271_bib0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2008.17.0746","article-title":"Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international phase III randomized controlled trial by the EORTC Radiation Oncology and Lu","volume":"27","author":"Slotman","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101271_bib0071","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30378-9","article-title":"Prophylactic cranial irradiation in small-cell lung cancer","volume":"18","author":"Rusthoven","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0073","first-page":"157","article-title":"Prophylactic cranial irradiation in patients with small cell lung cancer in The Netherlands: A population-based study","volume":"27","author":"Tomassen","year":"2021","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101271_bib0074","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jtho.2016.04.031","article-title":"Current patterns of care for patients with extensive-stage SCLC: survey of U.S. Radiation oncologists on their recommendations regarding prophylactic cranial irradiation","volume":"11","author":"Jain","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0075","doi-asserted-by":"crossref","first-page":"ix173","DOI":"10.1093\/annonc\/mdy483","article-title":"IMpower133: Primary efficacy and safety + CNS-related adverse events in a phase I\/III study of first-line (1L) atezolizumab + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)","volume":"29","author":"Mok","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0076","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases","volume":"316","author":"Brown","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101271_bib0077","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101271_bib0078","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.21037\/jtd.2020.03.90","article-title":"Radiosurgery for small-cell lung cancer brain metastases: a review","volume":"12","author":"Robin","year":"2020","journal-title":"J. Thorac. Dis."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101271_bib0079","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1470-2045(22)00271-6","article-title":"Stereotactic radiosurgery versus whole brain radiotherapy in patients with intracranial metastatic disease and small-cell lung cancer: a systematic review and meta-analysis","volume":"23","author":"Gaebe","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0080","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1200\/JCO.2024.42.16_suppl.2020","article-title":"Stereotactic radiosurgery in patients with small cell lung cancer and 1-10 brain metastases: A multi-institutional, phase II, prospective clinical trial","volume":"42","author":"Aizer","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0081","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s13063-018-2745-x","article-title":"Whole brain radiation therapy alone versus radiosurgery for patients with 1-10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial","volume":"19","author":"Bernhardt","year":"2018","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101271_bib0083","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2023.12.004","article-title":"Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101271_bib0084","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/path.5232","article-title":"The immunological consequences of radiation-induced DNA damage","volume":"247","author":"Wilkins","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.ctarc.2026.101271_bib0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:53:49Z","timestamp":1790913229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":83,"alternative-id":["S2468294226001826"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101271","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the management of small cell lung cancer: thoracic and cranial radiation therapy and sequencing with systemic therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101271"}}